Track topics on Twitter Track topics that are important to you
Phoenix, March 01, 2017 (GLOBE NEWSWIRE) -- / BioNovelus, Inc. (PINKSHEETS: ONOV) is proud to announce that it has acquired all certifications and licensures it believes necessary to sell and distribute products from newly established Guatemalan Subsidiary: BioNovelus-Guatemala S.A. in Guatemala.
Anacafé, the Guatemalan Coffee Association reports positive results for CR-10 in Phase I testing. CR-10 has proven to be the only effective organic, biodegradable fungicide to exterminate coffee rust with minimal impact on the eco system. (Source: Evelio Francisco Alvarado R., Anacafé General Manager) The Phase I testing will conclude with Anacafé “cupping test” of coffee treated with CR-10. The “cupping test” determines whether the taste of the coffee is affected by biodegradable, and eco-friendly fungicide CR-10. Bionovelus will report these results upon receipt.
Anacafé’s Phase II and final testing is two-fold and underway to evaluate the compatibility of CR-10 with residual chemical products originally used to treat coffee rust. Testing will determine whether CR-10 reduces the impact of the chemical residue in the coffee plants. Finally, testing on otherwise untreated organic coffee plantations will determine the maximum benefits of organic CR-10 to preserve the integrity of and “save” the organic coffee industry prior to any chemical treatments whatsoever.
Since coffee rust became an epidemic in Central America in 2012 (Source: Anacafé), there has not been any organic coffee rust killer to be approved by Anacafé (Guatemala) or ICafé (Costa-Rica), or any other coffee grower organization.
Additionally, the Guatemalan Chamber of Commerce has invited BioNovelus to take part in the AGRITRADE Expo & Conference, March 23 & 24, 2017. Agritrade, the largest international agricultural fair in Central America, scheduled bi-annually, “brings together international buyers and exporters of fresh and processed products of the region, involving suppliers and agricultural services in the supply chain.”
About Biofungicide CR-10
CR-10 is a proven, biodegradable, non-toxic solution that kills bacteria, fungi and spores rapidly, safely and effectively. It is a new generation of biofungicide with a unique mode of action. BioNovelus management believes that CR-10 has a broad range of uses in agricultural applications.
About BioNovelus Inc.
BioNovelus, Inc. (PINKSHEETS: ONOV) is a bioscience company that honors the environment with an innovative, cost effective and disruptive technology-based solution to agricultural and water problems.
The coffee industry is the second largest commodity market in the world to the oil industry (Source: Business Insider). Since the late 19th century, the coffee industry has been plagued by Coffee Rust or "Roya" (Hemileia vastatrix) a devastating fungus that attacks the Arabica plant. Billions of dollars and hundreds of thousands of industry jobs have been lost throughout Central America since 2012 to this Coffee Rust epidemic. (Source: ICafé). The entire coffee belt from Indonesia to Africa, to Central and South America to Vietnam and Asia is seeking a remedy to this Coffee Rust epidemic.
We are determined to help coffee growers keep the better tasting strain of the Arabica plant by fighting coffee rust through our “green” CR-10 instead of being forced to change to “hybrid” type plants. We feel very strongly that our “green”, biodegradable product is not only better for our environment but for people who enjoy the rich flavor that comes from Arabica coffee beans, whether organic or not.
BioNovelus’ primary target market is the $100Billion* plus, annual, worldwide, coffee industry. (*Source: Business Insider)
This news release includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the Company's current expectations. Forward-looking statements are identified by words such as "anticipates," "projects," "expects," "plans," "intends," "believes," "estimates," "targets," and other similar expressions that indicate trends and future events.
Factors that could cause the Company’s results to differ materially from forward looking statements regarding the efficacy of the crop restoration and results of CR-10 and registration approval include the lack of capital needed to complete testing, the lack of experience with pursuing approval of this product and modifications and receipt of information that may be demanded by the registration of the CR-10 formula and the delays in the various government approval processes unrelated to the product itself. Factors that could cause lower rates of success in CR-10 eradication of fungi include the method and timing of applications of CR-10, the impact of heavy rainfall the strength of fungi contamination, and other environmental conditions resulting in re-infection. Factors that may impact Guatemalan acceptance of our product include: any changes in the taste of the coffee on the completion of the “cupping test”; and the compatibility with other chemical products.
There is no assurance of when registrations in Guatemala will be obtained for CR-10 and various applications as the Phase I and II testing is not completed. There is no assurance that the coffee rust application will prove commercially viable. There is no assurance that any transaction will be done with Guatemalan distributors.
Factors that could cause the Company's results to differ materially from those expressed in forward-looking statements include, without limitation, variation in demand and acceptance of the Company's products and services, general business and economic conditions beyond the Company's control the consequences of competitive factors in the marketplace including the ability to attract and retain customers, results of continuous improvement and other cost-containment strategies, taste of coffee when our products are used, compatibility with other chemical products, and the Company's success in attracting and retaining key personnel. The Company undertakes no obligation to revise or update forward-looking statements because of new information, since these statements may no longer be accurate or timely.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this press release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
For more information, contact http://bionovelus.com
Media contact: Nathalie Ekobo, Marketing & Communications Director BioNovelus, Inc. +1 602-888-3424 Info@BioNovelus.comNEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...